The FDA’s final guidance on power morcellators calls for them to only be used on younger women not suspected of having cancer, and only with the use of an approved tissue containment system.…
The FDA has issued a new draft guidance on the use of power morcellators linked to the spread of undiagnosed cancers, indicating they should only be used with adequate containment systems and only on certain patient populations.…
A new study finds that women with uterine sarcoma who undergo morcellation face a significantly higher risk of death.…
The FDA reports that risks of contracting uterine cancer from power morcellation could be as high as 1-in-225, and also warns that cancer spread through morcellation appears to be more deadly than other forms of uterine cancer.…
A new editorial say failures to more quickly identify and react to power morcellator cancer risk were in part due to a lack of a sound post-marketing surveillance system to ensure the safety and effectiveness of medical devices once they are on the market.…
A long-ignored technique known as embolization may be an under-used means of uterine fibroid removal, according to a new study. which comes as the medical community abandons morcellation procedures due to cancer risks.…
A GAO report indicates that the FDA’s adverse reporting system and its voluntary nature may have delayed the agency from detecting heightened cancer risks linked to the use of power morcellators.…
A new study warns that women over 50 may be more vulnerable to leiomyosarcoma cancer risks linked to the use of power morcellators.…
Olympus has received approval for a new morcellator equipped with a tissue containment bag, amid concerns that morcellators can spread cancerous cells throughout a woman’s body.…
Researchers have seen no increase in hysterectomy complications as the medical community walks back from power morcellator use over cancer fears, according to a new study.…
